Concepedia

Anne von Heideman

AV

Statistics

Publications

6

Citations

330

H-Index

6

Active since

1997

Affiliations

Uppsala University Hospital(Current)

Karolinska Institutet

Uppsala University

Sophiahemmet Hospital

Umeå University

Anne von Heideman is an author at Uppsala University Hospital specializing in medicine, oncology, and pharmacology.

Publications per year

1997–2020

6

Publications

6

Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data

Anne von Heideman, Åke Berglund, Rolf Larsson et al. · Cancer Chemotherapy and Pharmacology · 2009 · 194 citations · Full text

, , +16

A Novel B-cell Line (U-2932) Established from a Patient with Diffuse Large B-cell Lymphoma Following Hodgkin Lymphoma

Rose‐Marie Amini, Mattias Berglund, Richard Rosenquist et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2002 · 61 citations

, , +16

Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986‐91

Erik Forestier, Göran Gustafsson, Anne von Heideman et al. · Acta Paediatrica · 1997 · 23 citations

, , +17

Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis

Haile Mahteme, Anne von Heideman, Birgitta Grundmark et al. · European Journal of Surgical Oncology · 2007 · 21 citations

, , +12

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma

Bengt Tholander, Anthoula Koliadi, Johan Botling et al. · Upsala Journal of Medical Sciences · 2020 · 18 citations · Full text

, , +17

1–5 of 6